Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger SWIM-type containing protein 4 (ZSWIM4) is a member of the ZSWIM family of proteins, characterized by the presence of a SWIM-type zinc finger domain, which confers DNA- and protein-binding capabilities[1][3]. ZSWIM4 is localized to the nucleus and predicted to function as a substrate adaptor in E3 ubiquitin ligase complexes, specifically Cul2-RING ligase assemblies, by forming complexes with Elongin B, Elongin C, and CUL2[2][3][4]. Functionally, ZSWIM4 attenuates BMP (bone morphogenic protein) signaling during embryonic patterning by promoting nuclear ubiquitination and degradation of SMAD1[2]. It is expressed across multiple tissues, with elevated levels reported in the brain and kidney[1]. While ZSWIM4 has been implicated as required for JAK2 inhibition resistance in breast cancer, there is no current evidence of direct drug targeting or biomarker usage in a clinical context[5]. Its main identified biological roles are in protein ubiquitination, negative regulation of BMP signaling, and embryonic developmental patterning[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger SWIM-type containing protein 4 (ZSWIM4).